Burst-pause criterion derivation for drinkometer measurements of ingestive behavior.
Michele Serra, Bálint File, Daniela Alceste...
https://pubmed.ncbi.nlm.nih.gov/35620756/Actively Recruiting
Led by University of Zurich · Updated on 2026-05-18
420
Participants Needed
2
Research Sites
17 weeks
Total Duration
Researchers are investigating how bariatric surgery, including Sleeve Gastrectomy SG and Roux-en-Y gastric bypass RYGB, affects eating and drinking behaviors in people with obesity. The study focuses on understanding these behaviors beyond self-reported food intake by using a special device called the drinkometer. This research also explores differences between males and females and examines how changes in gut hormone levels relate to these behaviors and body weight loss over time. The study observes adults with obesity undergoing SG or RYGB surgery, as well as control groups including people with obesity not having surgery and individuals with normal weight. Using the drinkometer, the study measures detailed aspects of ingestive behavior before and up to one year after surgery. Additionally, it investigates hormone levels after eating and compares results between sexes. A subgroup of patients who had RYGB surgery five years ago is also studied to explore long-term associations between ingestive behavior, hormone levels, and weight loss. Participants will undergo assessments of their drinking behavior using the drinkometer device, and blood samples will be taken to measure gut hormone levels. Data collection occurs before surgery and at various times up to one year after, with a separate evaluation for those five years post-surgery. The study measures detailed behavioral patterns, hormone effects, and body weight changes to understand the impact of bariatric surgery. The total study duration varies depending on the participant group, and safety and adherence are monitored throughout the research period.
CONDITIONS
Direct Measurement of Ingestive Behaviour in Relation to Sex Differences and Gastrointestinal Hormone Levels in Patients After Metabolic and Bariatric Surgery
M
Marco Bueter, MD, DPhil
M
Michele Serra, PhD
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here
University of Zurich
Lead Sponsor
Florida State University
Collaborating Sponsor
You may qualify if you...
You will not qualify if you...
Duration - 2 to 4 weeks
Participants are screened for eligibility to participate in the trial.
1 visit (in-person)
Duration - Up to 1 year
Participants undergo assessments of ingestive behaviour and gut hormone levels before undergoing bariatric surgery or as part of observational groups.
Multiple visits over the year for measurements
Duration - At 5 years after surgery
Participants who had Roux-en-Y Gastric Bypass surgery 5 years prior are observed for ingestive behaviour, gut hormone levels, and body weight outcomes.
1 to 2 visits depending on participant group
Study Type
OBSERVATIONAL
Masking
N/A
Allocation
N/A
Model
N/A
Primary Purpose
N/A
Number of Arms
8
Have more questions? Get in touch with our team for quick support
Michele Serra, Bálint File, Daniela Alceste...
https://pubmed.ncbi.nlm.nih.gov/35620756/Daniel Gero, Robert E Steinert, Carel W le Roux...
https://pubmed.ncbi.nlm.nih.gov/28779431/Thomas A Lutz, Marco Bueter
https://pubmed.ncbi.nlm.nih.gov/24819493/Daniel Gero, Balint File, Jörn Justiz...
https://pubmed.ncbi.nlm.nih.gov/30179650/Carel W le Roux, Marco Bueter
https://pubmed.ncbi.nlm.nih.gov/25210112/Daniel Gero, Bálint File, Daniela Alceste...
https://pubmed.ncbi.nlm.nih.gov/34369388/Daniela Alceste, Michele Serra, Ivana Raguz...
https://pubmed.ncbi.nlm.nih.gov/35134394/University of Zurich
Lead Sponsor
Florida State University
Collaborating Sponsor